Author Question: A patient with asthma has been prescribed ipratropium (Atrovent) 2 puffs QID. The nurse should ... (Read 59 times)

RRMR · **on:** Jul 23, 2018

A patient with asthma has been prescribed ipratropium (Atrovent) 2 puffs QID. The nurse should recognize which of the following as the most likely goal of this treatment?

A) Promoting short-term relief of acute asthma symptoms
B) Relieving acute bronchoconstriction
C) Promoting long-term management of asthma symptoms
D) Promoting blood flow in the alveolar capillaries

Question 2

A woman is seen in the primary care provider's office with chronic severe diarrhea-predominant irritable bowel syndrome, which has not responded to conventional therapy. Which medication should the nurse anticipate administering?

A) Rifaximin (Xifaxan)
B) Nitazoxanide (Alinia)
C) Alosetron (Lotronex)
D) Cholestyramine (Questran)

JCABRERA33 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

C
Feedback:
The anticholinergic bronchodilators are most useful in the long-term management of asthma and other conditions producing bronchoconstriction . These drugs are not used in the management of acute exacerbations of asthma. They do not promote alveolar blood flow.

Answer to Question 2

C
Feedback:
Alosetron (Lotronex) is a selective 5-HT3 receptor antagonist indicated for treating women with chronic severe diarrhea-predominant irritable bowel syndrome that has not responded to conventional therapy. Rifaximin (Xifaxan) is a nonsystemic antibiotic that would not be prescribed for this patient. Nitazoxanide (Alinia) is an antiprotozoal agent used for Giardia lamblia. Cholestyramine (Questran) is a bile-binding drug and is not the drug of choice for this patient.